✦ LIBER ✦

AMG 145, a Monoclonal Antibody Against PCSK9, Facilitates Achievement of National Cholesterol Education Program–Adult Treatment Panel III Low-Density Lipoprotein Cholesterol Goals Among High-Risk Patients

✍ Scribed by Desai, Nihar R.; Giugliano, Robert P.; Zhou, Jing; Kohli, Payal; Somaratne, Ransi; Hoffman, Elaine; Liu, Thomas; Scott, Robert; Wasserman, Scott M.; Sabatine, Marc S.

Book ID: 122296181
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 371 KB
Volume: 63
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2013.09.048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Undertreatment among high-risk dyslipide

Undertreatment among high-risk dyslipidemic patients: results of a national survey of goal achievement for National Cholesterol Education Program Adult Treatment Panel III guidelines

✍ M. H. Davidson; K. C. Maki; T. A. Pearson; R. C. Pasternak; For The Neptune Stee 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Treatment of High-Risk patients with eze

Treatment of High-Risk patients with ezetimibe plus simvastatin Co-Administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III Low-Density lipoprotein cholesterol goals

✍ Theodore Feldman; Michael Koren; William Insull Jr.; James McKenney; Helmut Schr 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 92 KB

M.511 Treatment of high risk patients wi

M.511 Treatment of high risk patients with ezetimibe plus simvastatin coadministration versus simvastatin alone to attain national cholesterol education program adult treatment panel III low-density lipoprotein cholesterol goals

✍ Feldman, T.; Koren, M.; Insull, W.; McKenney, J.; Schrott, H.; Lwein, A.; Shah, 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 138 KB